Sun pharma price chart
Get Live Sun Pharmaceutical Industries stock market chart. Free Sun Pharma Historic stock charts for NSE / BSE. Get Sun Pharmaceutical Industries detailed stock quotes and technical charts for Sun Looks like a double bottom on the weekly for Sun Pharma. It can play out over 2-3 months. It should head higher to 450-470 levels. Of course it is counter trend and any sell off to 375-380 zone would negate this view. India's Sun Pharma flags hypertension drug shortage due to supply constraint. Indian drugmaker Sun Pharmaceutical Industries Ltd said on Monday there was a shortage of its generic version of Sun Pharma third-quarter profit jumps four-fold on strong U.S. show Net profit came in at 12.42 billion rupees ($175.45 million) versus 3.22 billion rupees profit last year, the company said, which was above an average estimate for a profit of 9.86 billion rupees from 16 analysts, Refinitiv Eikon data shows.
SUNPHARMA Share Price - Sun Pharmaceuticals Industries Limited NSE INDIA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts.
Find the latest SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharma Inds. Charts for NSE, BSE - Stock Market Chart Sun Pharma Inds. Share Price, Sun Pharma Inds. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Price Data sourced from NSE feed, price updates are near real-time, unless indicated. Financial data sourced from CapitalMarket. Technical/Fundamental Analysis Charts & Tools provided for research purpose. Please be aware of the risk's involved in trading & seek independent advice, if necessary. SUN PHARMACEUTICAL INDUSTRIES LTD. Stock technical analysis with dynamic chart and End-of-day quote | NSE India Stock Exchange: SUNPHARMA | NSE India Stock Exchange. SUN PHARMACEUTICAL INDUSTRIES LTD. Stock technical analysis with dynamic chart and End-of-day quote | NSE India Stock Exchange: SUNPHARMA | NSE India Stock Exchange view the price, resistance, support, chart of Sun Pharmaceuticals Industries Limited and plot charts along with its volumes. Also see the 52-week high and low prices.
Discover historical prices for SUNPHARMA.NS stock on Yahoo Finance. View daily, weekly or monthly formats back to when SUN PHARMACEUTICAL stock
Sun Pharma Inds. Charts for NSE, BSE - Stock Market Chart Sun Pharma Inds. Share Price, Sun Pharma Inds. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Price Data sourced from NSE feed, price updates are near real-time, unless indicated. Financial data sourced from CapitalMarket. Technical/Fundamental Analysis Charts & Tools provided for research purpose. Please be aware of the risk's involved in trading & seek independent advice, if necessary. SUN PHARMACEUTICAL INDUSTRIES LTD. Stock technical analysis with dynamic chart and End-of-day quote | NSE India Stock Exchange: SUNPHARMA | NSE India Stock Exchange. SUN PHARMACEUTICAL INDUSTRIES LTD. Stock technical analysis with dynamic chart and End-of-day quote | NSE India Stock Exchange: SUNPHARMA | NSE India Stock Exchange view the price, resistance, support, chart of Sun Pharmaceuticals Industries Limited and plot charts along with its volumes. Also see the 52-week high and low prices. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for mid-term is a uptrend, and nearest possible future share price target is 454 or 467.40 Sun Pharmaceuticals is currently trading at 430.30
Looks like a double bottom on the weekly for Sun Pharma. It can play out over 2-3 months. It should head higher to 450-470 levels. Of course it is counter trend and any sell off to 375-380 zone would negate this view.
Sunpharma Stock Analysis, Research, Sunpharma Candlestick Chart Live. Get Sun Pharmaceutical Industries Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details.
Share Price History of Sun Pharmaceutical Industries Ltd. Date, Open, High, Low, Close, Volume. 17-Mar-20, 376.00, 395.60, 364.20
Nov 8, 2019 CK Narayan of Chart Advise has a buy call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 450. The current market price of Sun Sun Pharmaceutical Industries Ltd. was incorporated in the year 1993. Its today's share price is 362.5. Its current market capitalisation stands at Rs 86939.9 Cr. Financial Year, Interim or Final, Rate of Dividend, Dividend per Equity Share ( Rupees), Face Value, Book-closure (both days inclusive), Date of Declaration of Share Price History of Sun Pharmaceutical Industries Ltd. Date, Open, High, Low, Close, Volume. 17-Mar-20, 376.00, 395.60, 364.20 See the split history of Sun Pharmaceutical Industries Ltd. along with Announcement, Record, Ex-split dates, old and new Face Values. Price to Book Value. Stock analysis for Sun Pharmaceutical Industries Ltd (SUNP:Natl India) including stock price, stock chart, company news, key statistics, fundamentals and See actual and adjusted dividend yields and history of Sun Pharmaceutical At the current share price of Rs 362.75, this results in a dividend yield of 1.59%.
Sep 6, 2019 The share price of Sun Pharma fell 4.01% to Rs 414.60 after the company accepted the allegations of a SEBI ordered forensic audit on Summary · Quotes · Charts · News More. Calendar · Company · Financials · Consensus · Revisions. Quantcast. Get Live Sun Pharmaceutical Industries stock market chart. Free Sun Pharma Historic stock charts for NSE / BSE. Get Sun Pharmaceutical Industries detailed stock quotes and technical charts for Sun Looks like a double bottom on the weekly for Sun Pharma. It can play out over 2-3 months. It should head higher to 450-470 levels. Of course it is counter trend and any sell off to 375-380 zone would negate this view. India's Sun Pharma flags hypertension drug shortage due to supply constraint. Indian drugmaker Sun Pharmaceutical Industries Ltd said on Monday there was a shortage of its generic version of Sun Pharma third-quarter profit jumps four-fold on strong U.S. show Net profit came in at 12.42 billion rupees ($175.45 million) versus 3.22 billion rupees profit last year, the company said, which was above an average estimate for a profit of 9.86 billion rupees from 16 analysts, Refinitiv Eikon data shows.